Form D · Other Technology
Apeiron Labs, Inc.
Cambridge, MA · CIK 0001933295
Offering snapshot reported Aug 19, 2025 · SEC filing
- Reported sold
- $7.75M Offering amount: $10.9M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2025 | Initial | $7,749,994 | No comparison | 4 | SEC filing |
| Jun 16, 2022 | Initial | $4,999,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-555241
Source: Form D, filed Aug 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Abbott | Director |
| David Douglas | Director |
| Sanjeev Krishnan | Director |
| Ravikanth Pappu | Director, Executive |
| Jonathan Rosen | Director |
| Kyle Teamey | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
486 Green Street
Cambridge, MA, 02139
Cambridge, MA, 02139